GGrantIndex
← Search

ACTG A5163: A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ON

$6,729M01FY2004RRNIH

University Of Minnesota Twin Cities, Minneapolis MN

Investigators

Linked publications & trials

View original record on NIH RePORTER →